Non-bacterial thrombotic endocarditis in a patient with COVID.


Journal

BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291

Informations de publication

Date de publication:
21 Oct 2023
Historique:
medline: 30 10 2023
pubmed: 22 10 2023
entrez: 21 10 2023
Statut: epublish

Résumé

Non-bacterial thrombotic endocarditis is mainly associated with malignancies and rheumatological diseases. We report the case of mildly symptomatic COVID-19 infection with non-bacterial aortic valve vegetation complicated by transient ischemic attack (TIA) and pulmonary embolism during his hospitalisation. This case emphasised rare life-threatening complications from a hypercoagulable state related to COVID-19 infection. To the best of our knowledge, this is the third case report of non-bacterial endocarditis in a patient with COVID-19 patients as a potential rare complication of COVID-19.

Identifiants

pubmed: 37865419
pii: 16/10/e256264
doi: 10.1136/bcr-2023-256264
pmc: PMC10603479
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© BMJ Publishing Group Limited 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Front Cardiovasc Med. 2023 Jul 12;10:1208190
pubmed: 37502185
Thromb Res. 2017 Jan;149:45-47
pubmed: 27888769
BMJ Case Rep. 2022 Mar 16;15(3):
pubmed: 35296493
Am J Med. 2021 Mar;134(3):361-369
pubmed: 32827467
N Engl J Med. 2021 Aug 26;385(9):777-789
pubmed: 34351722
Prog Cardiovasc Dis. 2022 Sep-Oct;74:99-110
pubmed: 36279942
Chest. 2012 Feb;141(2 Suppl):e576S-e600S
pubmed: 22315272
Lancet. 2021 Jun 12;397(10291):2253-2263
pubmed: 34097856
Circulation. 2020 Aug 11;142(6):611-614
pubmed: 32776849
Am Heart J. 1976 Dec;92(6):723-9
pubmed: 998478
Lancet. 2022 Jan 1;399(10319):50-59
pubmed: 34921756
Mayo Clin Proc. 2001 Dec;76(12):1204-12
pubmed: 11761501
Am J Med. 1987 Oct;83(4):746-56
pubmed: 3674060
Eur J Case Rep Intern Med. 2021 Mar 19;8(3):002409
pubmed: 33869101
JAMA. 2020 Aug 25;324(8):799-801
pubmed: 32702090

Auteurs

Ali Ahmad (A)

Department of Medicine, Saint Louis University School of Medicine, Saint Louis, Missouri, USA.

Lolita Golemi (L)

Department of Medicine, Saint Louis University School of Medicine, Saint Louis, Missouri, USA.

Rohil Bedi (R)

Department of Medicine, Saint Louis University School of Medicine, Saint Louis, Missouri, USA.

Kristen M Sanfilippo (KM)

Department of Medicine, Washington University in St. Louis School of Medicine, Saint Louis, Missouri, USA.
Department of Medicine, VA St Louis HealthCare System, Saint Louis, Missouri, USA.

Nongnooch Poowanawittayakom (N)

Department of Medicine, Saint Louis University School of Medicine, Saint Louis, Missouri, USA.

Jiafu Ou (J)

Department of Medicine, Washington University in St. Louis School of Medicine, Saint Louis, Missouri, USA jou@wustl.edu.
Department of Medicine, VA St Louis HealthCare System, Saint Louis, Missouri, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH